LDS buys Kaolectrolyte, Prodium
This article was originally published in The Tan Sheet
Cedar Rapids, Iowa-based LDS Consumer Products acquires U.S. marketing, distribution rights to Kaolectrolyte oral rehydration therapy for infants, children under six and Prodium urinary tract infection treatment from Requa, firm announces June 6. Kaolectrolyte competes against Ross' Pedialyte, while Prodium competitors include J&J's Uristat and PolyMedica's Azo-Standard; all three contain active phenazopyridine 95 mg. LDS obtained exclusive U.S. sales and marketing rights to Wartner Wart Removal System in 2002 (1"The Tan Sheet" April 28, 2003, p. 4)...
You may also be interested in...
LDS Consumer Products' Wartner is the first OTC wart removal product featuring cryotherapy technology, according to the Cedar Rapids, Iowa-based firm
FDA and CDC advisory committee members wonder how to use the single-shot J&J vaccine if an ongoing study shows two doses are better than one.
The firm’s acute migraine treatment Nurtec ODT generated $65m in 2020 after launching a year ago. Biohaven aims for Nurtec to become the leader in what could be a $4bn-$5bn category in the US.